Cutler Group’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-8,100
| Closed | -$226K | – | 5819 |
|
|
2020
Q3 | $226K | Buy |
8,100
+3,200
| +65% | +$162K | 0.01% | 861 |
|
|
2020
Q2 | $22K | Buy |
+4,900
| New | +$143K | ﹤0.01% | 2338 |
|
|
2020
Q1 | – | Sell |
-6,000
| Closed | -$4K | – | 4962 |
|
|
2019
Q4 | $4K | Buy |
+6,000
| New | +$106K | ﹤0.01% | 3210 |
|
|
2019
Q3 | – | Sell |
-11,000
| Closed | -$6K | – | 4977 |
|
|
2019
Q2 | $6K | Buy |
+11,000
| New | +$166K | ﹤0.01% | 3035 |
|
|
2019
Q1 | – | Sell |
-22,100
| Closed | -$48K | – | 5057 |
|
|
2018
Q4 | $48K | Buy |
22,100
+9,000
| +69% | +$179K | ﹤0.01% | 1498 |
|
|
2018
Q3 | $85K | Sell |
13,100
-2,100
| -14% | -$49.7K | 0.01% | 1297 |
|
|
2018
Q2 | $136K | Sell |
15,200
-100
| -0.7% | -$2.01K | 0.01% | 961 |
|
|
2018
Q1 | $50K | Sell |
15,300
-101,300
| -87% | -$1.66M | ﹤0.01% | 1671 |
|
|
2017
Q4 | $760K | Buy |
116,600
+35,100
| +43% | +$414K | 0.03% | 394 |
|
|
2017
Q3 | $604K | Sell |
81,500
-17,700
| -18% | -$176K | 0.02% | 562 |
|
|
2017
Q2 | $361K | Buy |
99,200
+43,500
| +78% | +$305K | 0.01% | 883 |
|
|
2017
Q1 | $128K | Buy |
55,700
+43,200
| +346% | +$219K | 0.01% | 1524 |
|
|
2016
Q4 | $11K | Buy |
12,500
+5,400
| +76% | +$16K | ﹤0.01% | 4147 |
|
|
2016
Q3 | $5K | Sell |
7,100
-4,600
| -39% | -$12.9K | ﹤0.01% | 5034 |
|
|
2016
Q2 | $4K | Buy |
11,700
+8,000
| +216% | +$26.7K | ﹤0.01% | 5232 |
|
|
2016
Q1 | $1K | Sell |
3,700
-27,600
| -88% | -$62.1K | ﹤0.01% | 6249 |
|
|
2015
Q4 | $7K | Buy |
+31,300
| New | +$87.4K | ﹤0.01% | 4617 |
|
Cutler Group's IMMU Position: Q4 2020 in Review
Cutler Group sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 19,900 shares — an estimated $1.69M sold.
Cutler Group first reported a position in IMMU in Q4 2015 and held it in 14 quarters. The position peaked at $1.69M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Cutler Group reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Cutler Group sold 19,900 Immunomedics Inc shares in Q4 2020, an estimated $1.69M.
- Cutler Group first reported a position in Immunomedics Inc in Q4 2015 and held it in 14 quarters.
- Cutler Group's Immunomedics Inc position peaked at $1.69M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Cutler Group's 13F filing for Q4 2020, filed 21 Jan 2021.